Prelude Capital Management, LLC Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$1.39 - $2.21 $15,984 - $25,415
-11,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.27 - $3.42 $14,605 - $39,330
11,500 New
11,500 $23,000
Q4 2020

Feb 16, 2021
SELL
$0.94 - $1.89 $4,418 - $8,883
-4,700 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$1.5 - $9.38 $7,050 - $44,086
4,700 New
4,700 $8,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.35B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email